Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ji-Fan Hu

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Theranostics|December 8, 2025
Mitochondria-specific targeting of noncanonical <i>EGR1</i> ntmRNA-coordinated mitophagy receptor BNIP3 homodimerization disrupts mitochondrial metabolism and suppresses hepatocellular carcinoma growth <i>in vitro</i> and <i>in vivo</i>Yan Li, Lei Zhou, Mengmeng Liu, et al.
American Journal of Cancer Research|June 21, 2019
Aberrant shuttling of long noncoding RNAs during the mitochondria-nuclear crosstalk in hepatocellular carcinoma cellsYijing Zhao, Shanshan Liu, Lei Zhou, et al.
The Journal of Biological Chemistry|February 1, 2002
An imprinted PEG1/MEST antisense expressed predominantly in human testis and in mature spermatozoaTao Li, Thanh H Vu, Kok-Onn Lee, et al.
Molecular Cancer|November 23, 2012
Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting systemZhen-Lin Nie, Yu-Qin Pan, Bang-Shun He, et al.
Genome Biology|December 13, 2018
A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1Naifei Chen, Gang Zhao, Xu Yan, et al.
Nucleic Acids Research|February 15, 2020
Oplr16 serves as a novel chromatin factor to control stem cell fate by modulating pluripotency-specific chromosomal looping and TET2-mediated DNA demethylationLin Jia, Yichen Wang, Cong Wang, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis CompetitionLingling Pian, Xue Wen, Lihua Kang, et al.
Nature Communications|July 14, 2017
Manipulation of nuclear architecture through CRISPR-mediated chromosomal loopingStefanie L Morgan, Natasha C Mariano, Abel Bermudez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2022
LncRNA Osilr9 coordinates promoter DNA demethylation and the intrachromosomal loop structure required for maintaining stem cell pluripotencyYanbo Zhu, Zi Yan, Changhao Fu, et al.
American Journal of Cancer Research|September 10, 2019
Profiling the epigenetic interplay of lncRNA RUNXOR and oncogenic RUNX1 in breast cancer cells by gene in situ cis-activationYuanyuan Nie, Lei Zhou, Hong Wang, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Theranostics|December 8, 2025
Mitochondria-specific targeting of noncanonical <i>EGR1</i> ntmRNA-coordinated mitophagy receptor BNIP3 homodimerization disrupts mitochondrial metabolism and suppresses hepatocellular carcinoma growth <i>in vitro</i> and <i>in vivo</i>Yan Li, Lei Zhou, Mengmeng Liu, et al.
American Journal of Cancer Research|June 21, 2019
Aberrant shuttling of long noncoding RNAs during the mitochondria-nuclear crosstalk in hepatocellular carcinoma cellsYijing Zhao, Shanshan Liu, Lei Zhou, et al.
The Journal of Biological Chemistry|February 1, 2002
An imprinted PEG1/MEST antisense expressed predominantly in human testis and in mature spermatozoaTao Li, Thanh H Vu, Kok-Onn Lee, et al.
Molecular Cancer|November 23, 2012
Gene therapy for colorectal cancer by an oncolytic adenovirus that targets loss of the insulin-like growth factor 2 imprinting systemZhen-Lin Nie, Yu-Qin Pan, Bang-Shun He, et al.
Genome Biology|December 13, 2018
A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1Naifei Chen, Gang Zhao, Xu Yan, et al.
Nucleic Acids Research|February 15, 2020
Oplr16 serves as a novel chromatin factor to control stem cell fate by modulating pluripotency-specific chromosomal looping and TET2-mediated DNA demethylationLin Jia, Yichen Wang, Cong Wang, et al.
Molecular Therapy. Nucleic Acids|September 10, 2018
Targeting the IGF1R Pathway in Breast Cancer Using Antisense lncRNA-Mediated Promoter cis CompetitionLingling Pian, Xue Wen, Lihua Kang, et al.
Nature Communications|July 14, 2017
Manipulation of nuclear architecture through CRISPR-mediated chromosomal loopingStefanie L Morgan, Natasha C Mariano, Abel Bermudez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2022
LncRNA Osilr9 coordinates promoter DNA demethylation and the intrachromosomal loop structure required for maintaining stem cell pluripotencyYanbo Zhu, Zi Yan, Changhao Fu, et al.
American Journal of Cancer Research|September 10, 2019
Profiling the epigenetic interplay of lncRNA RUNXOR and oncogenic RUNX1 in breast cancer cells by gene in situ cis-activationYuanyuan Nie, Lei Zhou, Hong Wang, et al.
Pageof 10